Transition to sarcopenia and determinants of transitions in older adults: A population-based study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 6, 2014, Pages 751-758

  Murphy, Rachel A ^a   Ip, Edward H ^b   Zhang, Qiang ^b   Boudreau, Robert M ^c   Cawthon, Peggy M ^d   Newman, Anne B ^c   Tylavsky, Frances A ^e   Visser, Marjolein ^f,g   Goodpaster, Bret H ^h   Harris, Tamara B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Epidemiology; Muscle; Physical function; Sarcopenia

Indexed keywords

AGE; AGED; AGING; ARTICLE; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EPIDEMIOLOGY.; FEMALE; HUMAN; INCIDENCE; MALE; MOTOR ACTIVITY; MULTICENTER STUDY; MUSCLE; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSICAL FUNCTION; PHYSIOLOGY; SARCOPENIA; SEX DIFFERENCE;

AGING; EPIDEMIOLOGY.; MUSCLE; PHYSICAL FUNCTION; SARCOPENIA;

ABSORPTIOMETRY, PHOTON; AGE FACTORS; AGED; AGING; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MALE; MOTOR ACTIVITY; MUSCLE STRENGTH; SARCOPENIA; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892854332     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt131     Document Type: Article

References (39)

1. Thompson DD. Aging and sarcopenia. J Musculoskelet NeuronalInteract. 20077:344-345.
2. Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C.The developmental origins of sarcopenia. J Nutr Health Aging.200812:427-432.
3. Paddon-Jones D, Short KR, Campbell WW, Volpi E, Wolfe RR.Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr.200887:1562S-1566S.
4. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, musclestrength, and muscle fat infiltration as predictors of incident mobilitylimitations in well-functioning older persons. J Gerontol A Biol SciMed Sci. 200560:324-333.
5. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes inskeletal muscles and their effect on mobility: an operational diagnosisof sarcopenia. J Appl Physiol. 200395:1851-1860.
6. Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value ofusual gait speed in well-functioning older people-results from theHealth, Aging and Body Composition Study. J Am Geriatr Soc.200553:1675-1680.
7. Morley JE, Abbatecola AM, Argiles JM, et al. Society on Sarcopenia,Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia withlimited mobility: an international consensus. J Am Med Dir Assoc.201112:403-409.
8. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European WorkingGroup on Sarcopenia in Older People. Sarcopenia: European consensuson definition and diagnosis: report of the European workinggroup on sarcopenia in older people. Age Ageing. 201039:412-423.
9. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosedcondition in older adults. Current consensus definition: prevalence,etiology, and consequences. International working group on sarcopenia.J Am Med Dir Assoc. 201112:249-256.
10. Newman AB, Kupelian V, Visser M, et al. Health ABC StudyInvestigators. Sarcopenia: alternative definitions and associations withlower extremity function. J Am Geriatr Soc. 200351:1602-1609.
11. Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ. Effect of10 days of bed rest on skeletal muscle in healthy older adults. JAMA.2007297:1772-1774.
12. Morley JE. Hormones and the aging process. J Am Geriatr Soc.200351(suppl 7):S333-S337.
13. Cesari M, Penninx BW, Pahor M, et al. Inflammatory markers andphysical performance in older persons: the InCHIANTI study. JGerontol A Biol Sci Med Sci. 200459:242-248.
14. Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia,obesity, and inflammation-results from the Trial of AngiotensinConverting Enzyme Inhibition and Novel Cardiovascular Risk Factorsstudy. Am J Clin Nutr. 200582:428-434.
15. Evans WJ, Farrell PA, Jefferson JS, Cherrington AD, eds. The agingpancreas: the effects of aging on insulin secretion and action. TheHandbook of Physiology. Oxford, UK: Oxford University Press2001: 969-998.
16. Zamboni M, Mazzali G, Zoico E, et al. Health consequences of obesityin the elderly: a review of four unresolved questions. Int J Obes(Lond). 200529:1011-1029.
17. Brach JS, Simonsick EM, Kritchevsky S, Yaffe K, Newman ABHealth, Aging and Body Composition Study Research Group. Theassociation between physical function and lifestyle activity and exercisein the health, aging and body composition study. J Am GeriatrSoc. 200452:502-509.
18. Ip EH, Jones AS, Heckert DA, Zhang Q, Gondolf ED. Latent Markovmodel for analyzing temporal configuration for violence profilesand trajectories in a sample of batterers. Socio Meth Res. 201039:222-255.
19. MacDonald I, Zucchini W. Hidden Markov and Other Models forDiscrete-valued Time Series. London: Chapman and Hall 1997.
20. Schwartz G. Estimating the dimensions of a model. Ann Stat. 19786:461-464.
21. Zhang QA, Jones AS, Rijmen F, Ip EH. Multivariate discrete hiddenMarkov models for domain-based measurements and assessmentof risk factors in child development. J Comput Graph Stat. 201019:746-765.
22. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiologyof sarcopenia among the elderly in New Mexico. Am J Epidemiol.1998147:755-763.
23. Marsh AP, Rejeski WJ, Espeland MA, et al. LIFE Study Investigators.Muscle strength and BMI as predictors of major mobility disabilityin the Lifestyle Interventions and Independence for Elders pilot(LIFE-P). J Gerontol A Biol Sci Med Sci. 201166:1376-1383.
24. Launer LJ, Harris T, Rumpel C, Madans J. Body mass index, weightchange, and risk of mobility disability in middle-aged and olderwomen. The epidemiologic follow-up study of NHANES I. JAMA.1994271:1093-1098.
25. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronicmusculoskeletal pain: a state of the art. Pain. 200085:317-332.
26. Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia:cytokine-driven hypermetabolism accompanying reduced body cellmass in chronic inflammation. J Clin Invest. 199493:2379-2386.
27. Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER.Racial differences in amounts of visceral adipose tissue in youngadults: the CARDIA (Coronary Artery Risk Development in YoungAdults) study. Am J Clin Nutr. 199969:381-387.
28. Perry AC, Applegate EB, Jackson ML, et al. Racial differences in visceraladipose tissue but not anthropometric markers of health- relatedvariables. J Appl Physiol. 200089:636-643.
29. Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletalmuscle strength, mass, and quality in older adults: the health,aging and body composition study. J Gerontol A Biol Sci Med Sci.200661:1059-1064.
30. Aloia JF, Vaswani A, Mikhail M, Flaster ER. Body composition bydual-energy X-ray absorptiometry in black compared with whitewomen. Osteoporos Int. 199910:114-119.
31. Visser M, Pahor M, Tylavsky F, et al. One-and two-year change inbody composition as measured by DXA in a population-based cohortof older men and women. J Appl Physiol. 200394:2368-2374.
32. Gourlay ML, Fine JP, Preisser JS, et al. Study of OsteoporoticFractures Research Group. Bone-density testing interval andtransition to osteoporosis in older women. N Engl J Med.2012366:225-233.
33. Lewiecki EM, Miller PD, Bilezikian JP. Bone-density testinginterval and transition to osteoporosis. N Engl J Med.2012366:1546-1547.
34. Cheung AM, Papaioannou A Osteoporosis Canada ScientificAdvisory Council Guidelines Committee. Bone-density testing intervaland transition to osteoporosis. N Engl J Med. 2012366:1546.
35. Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, PhillipsDI, Cooper C. Type 2 diabetes, muscle strength, and impairedphysical function: the tip of the iceberg? Diabetes Care200528:2541-2542.
36. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass(sarcopenia) in older persons is associated with functional impairmentand physical disability. J Am Geriatr Soc. 200250:889-896.
37. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcarecosts of sarcopenia in the United States. J Am Geriatr Soc.200452:80-85.
38. Visser M, Harris TB, Langlois J, et al. Body fat and skeletal musclemass in relation to physical disability in very old men and womenof the Framingham Heart Study. J Gerontol A Biol Sci Med Sci.199853:M214-M221.
39. Visser M, Langlois J, Guralnik JM, et al. High body fatness, but notlow fat-free mass, predicts disability in older men and women: theCardiovascular Health Study. Am J Clin Nutr. 199868:584-590.